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INTRODUCTION 
In 1925, Thomas Cooley and Pearl Lee described a form 
of severe anemia occurring in children of Italian origin, 
the Mediterranean region, Africa, Burma, Southeast 
Asia, including Southern China and Indonesia [1,2]. 
Worldwide there are about 15 million public have 
clinically noticeable with thalassemia major disorders. 
Out of this, about 240 million are carriers of β 
thalassemia with both types.  There are around 30 
million thalassemic children present in India [3]. 
β -Thalassemia major is associated with profound 
anemia characterized by extreme pallor, jaundice, or 
failure to thrive, accompanied by poor feeding, 
irritability, decreased activity, or increased drowsiness. 
These all characteristics lead towards saturation of 
surfeit iron in the various organs is mainly seen in 
homozygous thalassemia patients [4]. Diminished 
hemoglobin formation and RBC’s survival rate, which 
further ensuing in the glut of unaffected globin chains 
formation. These excess alpha globin chains form 
unstable homo-tetramers that further impulsive as 
inclusion bodies. It leads to severe RBC breakdown and 
lysis of RBCs. It leads to gross ineffective 
erythropoiesis (IE). The thalassemic symptoms usually 
appear within 2-4 months of the child's age [1].  
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The repeated blood transfusion and saturated unstable 
free α-globin’s together enhance more and more 
gastrointestinal iron absorption. This further leads to the 
iron burden in the body [5]. It is assumed that excess of 
unpaired globin chains coalesces to form Heinz bodies, 
which tend to precipitate in the cell and erythrocyte 
membrane [4].  The iron is a one-way mineral that only 
enters in the body. In addition to this, frequent blood 
transfusion leads to progressive iron accretion as there 
are no excretory pathways. The free iron species are 
principally accountable for the production of reactive 
oxygen species (ROS) [2].  
Earlier studies have shown that thalassemic patients are 
exposed to higher oxidative stress and possible 
consequential accelerated apoptosis. This contributes 
shorten life span as a result of excess production of 
reactive oxygen species such as superoxide anion (O2), 
hydroxyl radical (OH•), singlet oxygen, and hydrogen 
peroxide (H2O2) in the erythrocytes  [4,6,7]. 
Because of repeated blood transfusion and increased 
gastrointestinal iron absorption in the body leads to a 
violent circle of free radicals. This results in the 
generation of constant oxidative stress [5,8-10]. 
Provoked peroxidative tissue injury due to free radicals 
that escort the severe anemia. The enhanced oxidative 
stress and disturbed antioxidant defense system 
stimulate particular unavoidable complications. This 
accelerates the multi-organ deformity, especially organs 
that accumulate excess iron, including spleen, liver, 
heart, pancreas [9]. 
Antioxidants are critical protective compounds that 
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inactivate free radicals and ROS. They play an essential 
role in the defense of the cell from oxidative tissue 
injury. Superoxide radicals generated in excess 
following antioxidant of the isolated hemoglobin chain 
is an essential contributor to the hemolytic process; 
hence it is crucial to measure the erythrocyte superoxide 
dismutase (ESOD) activity in β-thalassemia major [5]. 
Catalase acts on H2O2 and hydroperoxide and serves as 
endogenous antioxidants [11]. 
The concentration of enzymatic antioxidant erythrocytic 
catalase was found to be considerably reduced when 
compared with healthy controls and baseline values. 
The concentration of erythrocyte superoxide dismutase 
enhanced in β-thalassemic patients as and when 
compared with healthy subjects.  The depleted activity 
of erythrocyte catalase in contrast with an enhanced 
superoxide dismutase and iron expose the existence of 
harsh oxidative stress in the RBCs of the β-thalassemia 
major patients which are on regular blood transfusion-
dependent [10, 11]. In homozygous thalassemia patients 
due presence of continued oxidative stress there is the 
poor thalassemic erythrocytes develops. This is mainly 
due to changes in RBC membrane protein pattern when 
compared to normal erythrocyte, further confirm that 
there was an enhanced free radical generation. This 
leads to an altered redox state, which is characterized by 
gross depletion of antioxidant enzymes and major 
nutrients [11-13]. 
 In homozygous thalassemia, there was severe 
antioxidants exhaustion resulting in inadequate 
protection due to secondary iron overload. Hence, the 
systematic massive scale of clinical trials in addition to 
regular treatment, which mainly involves the 
supplementation of combined antioxidant nutrients, may 
generate useful for the patients. Further, the antioxidant 
supplementation therapy in the form of A-Z syrup may 
be used as an adjunct therapy in homozygous beta-
thalassemia [13]. 
Keeping this view in mind, the present study was aimed 
to assess the serum iron levels, which leads to the 
generation of oxidative stress. To counteract these free 
radicals, we also evaluate the enzymatic antioxidant 
concentrations in homozygous thalassemia patients. 
MATERIAL AND METHODOLOGY    
Study design: Randomized, single-blinded trial. 
Ethical approval: The Institutional Ethical Committee 
clearance was taken from the institute, and informed 
consent was obtained.  
Study place: Department of Biochemistry, ACPM, 
Medical College, Dhule, (M.S.)  
Study duration: 12 months.  
Sample size: Total 120 subjects 
Inclusion criteria: This included 60 age and sex-
matched healthy normal and 60 β- thalassemia major 
children. All patients were already diagnosed by High-
Performance Liquid Chromatography (HPLC) and 
electrophoretic patterns. All thalassemic patients receive 
an oral dose of deferiprone as an iron chelator in regular 
dose (75mg/kg body weight/day or 100 mg/kg body 
weight/day as per the serum ferritin concentration). The 
blood transfusion-dependent aged between 3-12 years. 
The common hemoglobin concentration ranged between 3 
-7 gm/dl. During the study period, patients were under the 
strict supervision of medical professionals.  
Exclusion criteria: Patients having a history of CVS 
diseases, thyroid dysfunction, diabetes mellitus, which 
induce oxidative stress, were excluded from the study.  
Grouping: Group I: Normal healthy volunteers (n=60) 
Group II: Homozygous beta-thalassemia patients before 
and after the supplementation of antioxidants syrup A-Z 
for 20 weeks 
Methodology 
From each subject, 4 ml blood was collected aseptically 
from the antecubital vein.  All samples were centrifuged 
at 3000-3500 rpm for 15 min to separate serum and 
erythrocytes, respectively. Polythene tube with cork was 
used for the collection of separated serum and stored at -
200C till its use.  
Serum Iron estimation was carried out by Ramsay’s 
Dipyridyl Method [14]. Estimation of erythrocyte 
superoxide dismutase was done by Kajari Das Method 
[15]. Catalase activity in RBCs was determined as per the 
L. Goth method [16]. UV visible Spectrophotometer 
(Systronix) was used for further analysis of all 
parameters. 
The supplementation was given to the patient's group only 
in the form of an antioxidant tablet A-Z b.i.d., which was 
composed of predominantly antioxidant vitamins and 
trace elements. Antioxidant supplementation was not 
provided to the control group. The measurement of all 
parameters from patient groups was accomplished before 
and after the 20th weeks of the antioxidant 
supplementation. 
Statistical analysis: The statistical analysis was carried 
out by using the SPSS (Statistical Package for Social 
Sciences) software, version 16.0 for Windows. The 
Student ‘Z’ test was applied to assess the difference 
between means of intervention and normal and pre and 
post-intervention data. All group results were expressed 
in mean ± SD.   
RESULTS  
Table 1: Antioxidant status in blood samples of control 
and homozygous β-thalassemia children patients before 
and after  20 weeks supplementation of A- Z antioxidants 
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**, $$P<0.001 considered as highly significant. **Normal vs 
Group II before suppl of antioxidant, $$ Group 2 Before Vs 
after. Student ‘Z’ test was used for individual comparison.  
Table 1 illustrates drastically enhanced (p<0.001) levels 
of serum Iron and ESOD, and the mean value of 
erythrocyte catalase was lower (p<0.001) when judged 
with healthy normal. After 20 weeks of antioxidant 
supplementation to patients group, it was observed that 
a significant decrease in the levels of iron and 
erythrocyte superoxide dismutase as compared with 
baseline results. Similarly, erythrocyte catalase level 
was determined to be higher (p<0.001) at the end of 20th 
week of the antioxidant supplementation when 
compared with before supplementation results but not 
up to the control level. 
DISCUSSION 
The aptitude to approximate the allocation of excess 
iron to forecast its consequences and, therefore, to tailor 
treatment is amazingly imprecise [10]. Iron overload 
can be developed by two main mechanisms in beta-
thalassemia major, augmented iron absorption due to 
ineffective erythropoiesis and repeated and regular 
blood transfusion [17]. 
The practical management of iron overload requires 
reliable estimation of body iron content and distribution 
as well as an understanding of how iron overload 
translates into clinical consequences. The goal of 
transfusion involves the correction of anemia, 
suppression of erythropoiesis, and inhibition of 
increased gastrointestinal iron absorption [10]. As there 
are no excretory mechanism exits, excess iron gets 
deposited as hemosiderin and ferritin in the liver, 
spleen, endocardium 1. The accretion of noxious 
quantities of iron cause tissue damage which leads to 
the formation of reactive oxygen species such as 
hydroxyl radicals (OH•), superoxide anions (O2
-), singlet 
oxygen and hydrogen peroxide (H2O2) which  grossly 
provoke the oxidative stress  and tissue damage in 
thalassemia major patients via Fenton reaction  
 Fe2++H2O2                                     Fe
3++OH• + OH• - 
If the assembly of ROS surpassed the capacity of the 
production of the antioxidant system to eliminate these 
species, then it will lead to oxidative stress. This 
oxidative stress and potential consequential hastened 
apoptosis may contribute to shortening the RBCs life 
span, amenorrhoea, hypogonadism, other endocrine 
disorders, and osteoporosis  [18].   
Our findings are following Eliezer A. Rachmilewitz et 
al., Kuldeep K. Gupta et al., and Elam Ahed that there 
were significantly improved serum iron and ESOD 
levels in patients with homozygous beta-thalassemia as 
correlated with healthy normal [1,5,13]. After the 
supplementation of antioxidants A-Z syrup for 20 
weeks, there was a reduced activity of iron and ESOD 
were seen whereas catalase was enhanced significantly 
but not up to the control levels.  
Superoxide dismutase acts as the first line of defense 
against free radicals and ROS, which catalyzes the 
dismutation of superoxide anion radical (O2˙‾
‾) into 
H2O2 by reduction [5,13].
  
The increased ESOD activity was probably due to an 
increase in the proportion of younger RBC’s, and it was 
a compensatory mechanism to increase the ESOD in 
response to increased oxidative stress due to iron 
overload [1,4,7,13]. 
Attakorn et al. also observed a daily supplementation of 
vitamin E for three months. The level of glutathione 
peroxidase and ESOD were elevated significantly 
compared to normal and baseline levels of β-
thalassemia major patients [9]. 
Our findings are in union with the observations made by 
the Elham Abed Mahdi and Thasinas Dissayabutra et al. 
The supplementation of antioxidants vitamin E daily for 
90 days at the rate of 200 IU/day reduces the 
overactivity of ESOD in β-thalassemia major patients. 
Antioxidant plays a crucial role in the endogenous 
defense line against peroxidation of lipid membrane at 
an early stage through free radical quenching activity 
[13,19].  
Catalase is a foremost erythrocytic antioxidant enzyme 
hydrolyzing potent H2O2 at its low concentration to the 
water molecule. Our examinations show the drastically 
depleted activity of erythrocytic catalase in homozygous 
beta-thalassemia victims as compared to the normal 
before the antioxidant supplementation. These results 
support the hypothesis made by various researchers like 
Nandita Das et al., Gerli GC et al., Dibyendu 
Chakraborty et al. that increased the formation of 
hydrogen peroxide by the action of superoxide 
dismutase which can hinder various peroxidase enzyme 
activities. This may contribute to the further 
augmentation of oxidative stress [4,20,21]. 
Elevated activity of erythrocytic Catalase on the 30th 
day after the supplementation of antioxidants was 
observed in the thalassemic patient's group. Increased 
activity of Catalase suggests the decreased formation of 
H2O2 and reduces ROS. Supplementation of 
antioxidants neutralizes as well as reduces the formation 
of superoxide radicals and H2O2. 
All these findings suggest that daily supplementation of 
various antioxidants in the required amount boosts the 
immune response. It also helps to increase the 
antioxidant protection and depletion in lipid 
peroxidation, thereby reduction in oxidative tissue 
injury. 
CONCLUSION 
The core of the present study lies in the fact that there 
was increased oxidative stress in the form of serum iron, 
ferritin, ESOD, and reduced catalase activity in patients 
at baseline levels. Due to repeated and regular blood 
transfusion for the survival of beta thalassemic children 
results in enhanced free iron surplus and giving 
credence to serum ferritin levels, which causes the 
enhanced generation of oxidative stress. This leads to 
the development of various abnormalities in the body.   
The frequent and regular antioxidant syrup 
supplementation to the homozygous beta-thalassemia 
patients may improve the overall antioxidative status. 
Antioxidants neutralize the free radicals production 
along with the synthesis of the new RBCs and improve 
the overall concentration of hemoglobin.   
Clinical uses: To date, the treatment accessible for this 
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homozygous beta-thalassemia is the chelation of excess 
of iron, transplantation of bone marrow, and stem cell 
therapy. However, these treatments are costly, 
compromised by noncompliance, and hence these 
patients only depend on frequent blood transfusion 
throughout their life. One of the ways to may boost the 
survival rates of such homozygous thalassemic children 
is the inhibition of the consequence of oxidative stress. 
Combined antioxidant therapy with compliance on 
regular treatment had improved the antioxidant status, 
reduce hemolysis rate, and improve the hepatic status by 
both decrease liver iron concentration and the degree of 
liver fibrosis. 
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